Vitrolife AB (publ) (STO:VITR)
Sweden
· Delayed Price · Currency is SEK 206.00
-7.40 (-3.47%)
Feb 21, 2025, 5:29 PM CET
Vitrolife AB Revenue
In the year 2024, Vitrolife AB had annual revenue of 3.61B SEK with 2.76% growth. Vitrolife AB had revenue of 959.00M in the quarter ending December 31, 2024, with 5.97% growth.
Revenue
3.61B
Revenue Growth
+2.76%
P/S Ratio
7.73
Revenue / Employee
3.22M
Employees
1,120
Market Cap
27.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.61B | 97.00M | 2.76% |
| Dec 31, 2023 | 3.51B | 278.00M | 8.60% |
| Dec 31, 2022 | 3.23B | 1.55B | 92.39% |
| Dec 31, 2021 | 1.68B | 435.43M | 34.96% |
| Dec 31, 2020 | 1.25B | -234.56M | -15.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Elekta AB | 17.88B |
| Vimian Group AB | 4.29B |
| Bonesupport Holding AB | 814.46M |
Vitrolife AB News
- 23 days ago - Vitrolife AB (publ) GAAP EPS of SEK1.02, revenue of SEK 959M - Seeking Alpha
- 2 months ago - Vitrolife CFO Patrik Tolf to step down - Seeking Alpha
- 4 months ago - Vitrolife AB (publ) reports Q3 results - Seeking Alpha